The intervention group showed a significantly reduced incidence of repetitive atherothrombotic events (non-fatal myocardial infarction (MI), non-fatal stroke, or cardiovascular death) and a reduction in the C-reactive protein level. Here, CRP is linked to myocardial infarction.